Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

A recent theory about the basis for fragile X syndrome is now validated in a mouse model. The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors.

According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

To see if a treatment that targets NMDA receptors might be effective in fragile X, they tried an experimental drug called Glyx-13. This drug binds to the 2B subunit of NMDA receptors to augment ...

Twelve exciting new treatments, diagnostics and medical ... Among the 12 is an ambitious project to target Fragile X syndrome, a single gene defect which is the most common cause of autism ...

“The sooner a child with Fragile X syndrome gets treatment, the more opportunity there is for learning.” The Independent is ...

Findings open the door for new Fragile X treatments targeting the NMDA receptor’s 2B subunit. Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for ...

Considering taking supplements to treat fragile x syndrome? Below is a list of common natural remedies used to treat or reduce the symptoms of fragile x syndrome. Follow the links to read common ...

The Pennsylvania-based drugmaker expects between $820 million and $860 million this year from WAKIX, as it pushes its ...

To date, Spinogenix has received a U.S. FDA Orphan Drug designation for the treatment of both ALS and Fragile X syndrome. More information on Spinogenix can be found at www.spinogenix.com or foll ...